Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 1
2(25.0%)
Phase 2
2(25.0%)
8Total
N/A(4)
Phase 1(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07552922Not ApplicableRecruiting

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Role: collaborator

NCT06907121Phase 2Not Yet Recruiting

Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health

Role: collaborator

NCT06082128Not ApplicableUnknown

FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers

Role: collaborator

NCT03502109Not ApplicableCompleted

Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients.

Role: collaborator

NCT03525782Phase 1Unknown

Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC

Role: collaborator

NCT03525652Phase 1Unknown

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

Role: collaborator

NCT02570425Not ApplicableCompleted

Comparing Maintenance of Device Mastery With Turbohaler© vs. Spiromax© in Healthcare Professionals naïve to Both Devices

Role: collaborator

NCT01938976Phase 2Completed

Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels and Smoking Behavior Among Early Adolescents in Jordan

Role: lead

All 8 trials loaded